Oncology Advisory Committee

Prof. Alex A. Adjei is an accomplished researcher in the field of experimental therapeutics and clinical drug development. He is a Professor of Oncology and a Professor of Pharmacology at the Mayo College of Medicine (Rochester, USA), as well as a consultant in Medical Oncology at Mayo Clinic.

Prof. Solange Peters is an experienced scientist whose main research fields include discovery and validation in preclinical/clinical settings of new biomarkers for thoracic cancers and targeted therapy and immunotherapy. Prof. Peters runs the Thoracic Malignancies Program and the Medical Oncology Service in the Department of Oncology at the Lausanne University Hospital (CHUV) in Switzerland and manages the organization and coordination of clinical trials.

David E. Fisher, MD, PhD is an internationally known researcher, clinician and academic, who is Chief of the Massachusetts General Hospital Department of Dermatology at Harvard Medical School in Boston, Massachusetts (USA).

Elcin Zan, M.D. is dual board- certified radiologist specializing in Neuroradiology and Nuclear Medicine. She is an Assistant Professor of Clinical Radiology at Weill Cornell Medicine and an Assistant Attending Radiologist at the New York-Presbyterian Hospital-Weill Cornell Campus.

Oliver Sartor, M.D., is a medical oncologist in the Division of Medical Oncology in the Department of Oncology at Mayo Clinic in Rochester, Minnesota. Dr. Sartor serves as chair of the Genitourinary Cancer Disease Group and director of Radiopharmaceutical Clinical Trials across the enterprise for Mayo Clinic Comprehensive Cancer Center. Dr. Sartor joined the staff of Mayo Clinic in April 2023.

Prof. Jean-Yves Blay is a well-known scientist and a medical oncologist whose main research interests focus on clinical and basic research in sarcomas. Dr. Blay is a General Director of the Centre Leon Bérard, the Comprehensive Cancer of Lyon, France, as well as a Professor of Medicine at the Université Claude Bernard.

Prof. Dr. Stéphane Depil is an M.D., oncologist, and hematologist at the Léon Bérard Cancer Centre and group leader at the Cancer Research Center of Lyon, as well as adjunct Professor at University Claude Bernard Lyon in France. He was also appointed Visiting Professor at King’s College London.

Prof. Richard Herrmann is a leading expert in Oncology with extensive experience in cancer clinical trials methodology in Phases I–III. He is Professor of Oncology at the University of Basel and former Head of the Division of Oncology and the Department of Clinical Research at the University Hospital Basel.